Skip to main content
OpenTrials
Completed

NCT Number: NCT01731743

Evaluation of Visual Acuity and Patient Satisfaction With AT LISA TRI 839MP Intraocular Lenses

The purpose of the study is to evaluate the far, intermediate and near visual acuities with a trifocal IOL.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Carl Zeiss Meditec AG

Berlin, 10589, Germany

About this study

After bilateral cataract surgery, monocular and binocular uncorrected (UCVA) and best distance corrected visual acuity (BCVA) will be measured at far (4m), intermediate (80 cm) and near (40 cm) distance as well as the subjective refraction.

A patient questionnaire will be used to assess the patient satisfaction and spectacle independence.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Man or woman, over 50 years of age
  • Bilateral implantation of a trifocal intraocular lens
  • Capsular bag implantation

Exclusion criteria

  • Existing ocular pathology
  • Surgical complications
  • Corneal astigmatism ≥ 1.0D

Treatment and study plan

AT LISA tri 839MP

Device

Primary outcomes

  1. Intermediate visual acuity

    Time frame: up to 3 months postoperatively

    Monocular and binocular uncorrected and best distance corrected

Secondary outcomes

  1. near and far visual acuity

    Time frame: 1 and 3 month postoperatively

    Monocular and binocular uncorrected and best distance corrected

Other outcomes

  1. Patient satisfaction and spectacle independence

    Time frame: 1 and 3 month postoperatively

Sponsors and collaborators

Lead sponsor

Carl Zeiss Meditec AG

Industry

Registry information

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Nov 22, 2012
Registry last updated
Jan 29, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.